Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Urease plays an important role in the chemotactic motility of Helicobacter pylori in a viscous environment.

Nakamura H, Yoshiyama H, Takeuchi H, Mizote T, Okita K, Nakazawa T.

Infect Immun. 1998 Oct;66(10):4832-7.

2.

Chemotaxis and motility of Helicobacter pylori in a viscous environment.

Yoshiyama H, Nakamura H, Kimoto M, Okita K, Nakazawa T.

J Gastroenterol. 1999;34 Suppl 11:18-23.

PMID:
10616760
3.

Chemotaxis of Helicobacter pylori: a urease-independent response.

Yoshiyama H, Mizote T, Nakamura H, Okita K, Nakazawa T.

J Gastroenterol. 1998;33 Suppl 10:1-5.

PMID:
9840007
4.
5.

A novel in vitro effect of the mucosal protective agent sofalcone--inhibition of chemotactic motility in Helicobacter pylori.

Yoshiyama H, Nakamura H, Okamoto T, Okita K, Nakazawa T.

Aliment Pharmacol Ther. 2000 Apr;14 Suppl 1:230-6.

6.

Helicobacter pylori requires an acidic environment to survive in the presence of urea.

Clyne M, Labigne A, Drumm B.

Infect Immun. 1995 May;63(5):1669-73.

7.

Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori.

Anoushiravani M, Falsafi T, Niknam V.

J Med Microbiol. 2009 Oct;58(Pt 10):1309-13. doi: 10.1099/jmm.0.010876-0. Epub 2009 Jul 2.

PMID:
19574414
8.

Helicobacter pylori containing only cytoplasmic urease is susceptible to acid.

Krishnamurthy P, Parlow M, Zitzer JB, Vakil NB, Mobley HL, Levy M, Phadnis SH, Dunn BE.

Infect Immun. 1998 Nov;66(11):5060-6.

9.

Growth cycle of Helicobacter pylori in gastric mucous layer.

Nakazawa T.

Keio J Med. 2002 Dec;51 Suppl 2:15-9. Review.

10.

Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils.

Ohta T, Shibata H, Kawamori T, Iimuro M, Sugimura T, Wakabayashi K.

Biochem Biophys Res Commun. 2001 Jul 20;285(3):728-33.

PMID:
11453654
11.

Unique mechanism of Helicobacter pylori for colonizing the gastric mucus.

Yoshiyama H, Nakazawa T.

Microbes Infect. 2000 Jan;2(1):55-60. Review.

PMID:
10717541
12.
13.

Urea, fluorofamide, and omeprazole treatments alter helicobacter colonization in the mouse gastric mucosa.

Aristoteli LP, O'Rourke JL, Danon S, Larsson H, Mellgard B, Mitchell H, Lee A.

Helicobacter. 2006 Oct;11(5):460-8.

PMID:
16961809
14.

[Helicobacter pylori and urease activity--comparative study between urease positive and negative mutant strains].

Takahashi S, Igarashi H, Nakamura K, Masubuchi N, Saito S, Aoyagi T, Itoh T, Hirata I.

Nihon Rinsho. 1993 Dec;51(12):3149-53. Japanese.

PMID:
8283623
15.

Motility of urease-deficient derivatives of Helicobacter pylori.

Tan S, Berg DE.

J Bacteriol. 2004 Feb;186(3):885-8.

16.

Effect of omeprazole on Helicobacter pylori urease activity in vivo.

Stoschus B, Domínguez-Muñoz JE, Kalhori N, Sauerbruch T, Malfertheiner P.

Eur J Gastroenterol Hepatol. 1996 Aug;8(8):811-3.

PMID:
8864680
17.

The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.

Xiao ZP, Ma TW, Fu WC, Peng XC, Zhang AH, Zhu HL.

Eur J Med Chem. 2010 Nov;45(11):5064-70. doi: 10.1016/j.ejmech.2010.08.015. Epub 2010 Aug 12.

PMID:
20801557
18.

Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer.

Nakshabendi IM, Zhang QB, Mokhashi M, Gemmell CG, Lee FD, Russell RI.

Helicobacter. 1996 Sep;1(3):155-8.

PMID:
9398897
19.

Helicobacter pylori and plasma ammonia levels in cirrhotics: role of urease inhibition by acetohydroxamic acid.

Zullo A, Rinaldi V, Hassan C, Folino S, Winn S, Pinto G, Attili AF.

Ital J Gastroenterol Hepatol. 1998 Aug;30(4):405-9.

PMID:
9789138
20.

How Helicobacter pylori urease may affect external pH and influence growth and motility in the mucus environment: evidence from in-vitro studies.

Sidebotham RL, Worku ML, Karim QN, Dhir NK, Baron JH.

Eur J Gastroenterol Hepatol. 2003 Apr;15(4):395-401.

PMID:
12655260

Supplemental Content

Support Center